We have studied the accuracy of statistical parameters of dose distributions in brachytherapy using actual clinical implants. These include the mean, minimum and maximum dose values and the variance of the dose distribution inside the PTV and on the surface of the PTV. These properties have been studied as a function of the number of uniformly distributed sampling points. These parameters, or the variants of these parameters, are used directly or indirectly in optimization procedures or for a description of the dose distribution. The accurate determinaton of these parameters depends on the sampling point distribution from which they have been obtained.
I. INTRODUCTION
In contrast to external beam radiotherapy dose distributions, those in brachytherapy are significantly more non-uniform. For external beam radiotherapy a few hundred sampling points can achieve an accuracy of 5%. 1, 2 This is not true for brachytherapy. To date, no systematic studies exist for the accuracy of the statistical parameters of the brachytherapy dose distribution. Brachytherapy treatment planning systems in addition to DVHs also give statistical parameters of the dose distribution, including the minimum and maximum dose values inside the PTV.
Sampling of dose points, both for deriving the geometrical limits of the PTV and critical structures; and for using as points to specify the dose distribution, must play a central role in the optimization procedures for modern imaging based brachytherapy.
Real 3D anatomy based multiobjective dose optimization methods 3 requires the iterative calculation of dose-volume histograms (DVH) for the planning target volume (PTV), body sections and critical structures and the dose distribution on the surface of the PTV. The DVHs are usually calculated by sampling the dose distribution of a large number (> 10 5 ) of uniformly distributed random points inside the PTV, and within critical structures. Other single cost function optimization algorithms include those with constraints which are related to the dose distribution, to the PTV, and to critical structures. The latest methods use sets of points distributed on the PTV surface (that is, actually on the target contours), inside the PTV volume and within the critical structures. Classical treatment planning optimization includes statistical parameters such as D min , D mean and D max and the variance, or variants of these parameters 4 -8 where D mean is used indirectly. 3 In some cases, such as the prostate, a critical structure, in this example the urethra, is surrounded by the PTV volume giving a PTV that is not continuously filling the anatomical volume enclosed by the PTV outer contours. In such cases, points generated inside the 3D PTV contour surface must be ignored if they are within any critical structure. In addition, any points inside the PTV, critical structures and any tissue volume, which are also inside the catheters, should be ignored. These constraints are not incorporated within any current brachytherapy software.
The constraints are implemented by avoidance of points closer than a given distance to the catheters, which is determined by the outer radius of the catheters. It could also be a clinical decision to ignore small volumes adjacent to the catheters by specifying an additional margin to the physical catheter outer radius.
The main aim of some dose optimization algorithms is that a defined isodose surface should ideally conform to the shape of the PTV. Usually this shape is described by a set of sampling points and the algorithms try to minimize the variance of the dose values at these dose points. To accurately describe the 3D shape of the PTV surface, the sampling points have to be uniformly distributed on its surface. However, some methods which are based on the estimation of the minimum peripheral dose (MPD) or the equivalent of the minimum target dose (MTD) 9 , and which use dose points distributed on the PTV contours as a representation of the 3D PTV surface, could give biased results, since they do not obviously cover the whole PTV.
Points inside the PTV and critical structures are used for the calculation of the volume which is required for the normalization of the DVHs, and this can be achieved with a high accuracy by a simple Monte Carlo integration technique. Due to the high dose gradients, many more sampling points are generally required in brachytherapy for the accurate calculation of DVHs than in external beam radiotherapy.
We present in this paper a number of new algorithms for the efficient generation of dose points which are uniformly distributed on the surface of the PTV; firstly within the PTV, and also within organs at risk or other tissues of interest where the constraints relate to catheter location and diameter. The 3D anatomical volumes are represented by sets of cross-sectional contours. The results of implementation of these algorithms in a range of clinical implant situations are presented and discussed, and the benefits of the new algorithms are described.
II. METHODS
In this section a method is presented which generates sampling points inside a triangulated surface of the PTV and other objects. This includes the exclusion of volumes inside sources or catheters. Additionally a method is presented which generates sampling points on the whole surface of the PTV.
A. Points within a volume
We assume that every volume is represented by planar contours which are obtained from parallel cross-sectional images using either CT or MR. We also assume that when using the planar contours of a volume, its surface is represented by triangles using triangulation procedures such as described by Fuchs et al., 10 or Boissonnat et al. 11 The triangulation is assumed to cover the whole surface, including the surface of both ends of the object.
The catheters are considered as a special category of non-anatomical 3D objects and are defined as a list of catheter describing points in 3D space as described by Tsalpatouros et al. 12 and by the catheter outer radius with or without an additional clinical margin. For catheters with a typical very small outer radius of 1-2 mm, the triangulation is not a suitable method for reconstruction of the volume surface. Because of their typical cylindrical geometry the surface and the volume encompassed by the catheters is determined analytically.
The verification procedure consists of determining whether a point is inside the volume as described by the planar contours and its triangulated surface. The basic part of this procedure is essentially reduced to a 2D verification of whether a point is inside a given contour on a given plane.
Test of if a point is within a 2D contour
We consider a 2D contour as a closed polygon made up of N vertices (x i ,y i ) i, ∈ 1,..., N and work on the DICOM based world coordinate system. There are several methods which can prove if a point P=(x p ,y p ) is within such a polygon but the most efficient method is the topology-based method. In order to determine if a point P is inside the polygon we consider a horizontal ray emanating from P towards the right, see Fig. 1 .
We count the number of intersections of a ray with all edges of the polygon. If the number of edges of the polygon intersected by the ray is even then the point P is outside the polygon, and if the number of intersections is odd then the point P lies inside the polygon. This is a consequence of the Jordan curve theorem in topology and a proof is given by Courant et al. 13 There are some special cases when a ray passes exactly through a vertex. These situations can be considered using tie breaking rules or by a method such as described by Edelsbrunner et al. 14 
Test of if a point is within a volume
We have to determine whether a point is inside or outside a volume. The previously mentioned 2D algorithm for a test of a point inside a polygon can be extended to a test for a point inside a polyhedron. Due to the very high number of triangles, that is facets of the polyhedron, such a method would be computationally very inefficient. For this reason we use the following procedure to check if a point P with coordinates ( x p ,y p ,z p ) is inside the triangulated surface of a volume. We assume that the planar contours of the volume are parallel to the Z-axis and in the range [z min , z max ]. We test if the point is inside the bounding box described by the contours. If the result is positive then the point is between two image planes containing these contours: z p ∈ [z before , z after ].
In cases where the point under consideration lies on a plane containing the contour, we set the default as z before = z after = z p . We then test if the point is in the plane at z = z before . If the result is positive we test if it is inside the corresponding 2D contour. Otherwise, z p ≠ z before , we test the projections of the point on the cross-sectional planes at z before and z after relative to the volume contours in these planes.
If the projections of the point are inside both planes then the point is considered to be inside the volume, or if they are outside both planes then the point is considered to be outside the volume. If this is not the case which is relatively rare, then the object contour at z = z p is calculated by interpolating between the object contours at z=z before and z=z after and in a further procedure, it is verified whether the point is inside or outside the interpolated contour. This contour is obtained from the intersection points of the triangles of the triangulated object surface and a plane perpendicular to the Z-axis at z = z p , that is, through the point. 15 An additional test is then necessary to avoid the possibility that the point is at the same time inside any other contoured volume. An exception is the case when the volume under consideration is what we term the body. This includes the PTV, normal tissue and critical structures.
Test of if a point is outside a catheter
Various optimization methods require a knowledge of the average or maximum dose value that is within a given volume such as the PTV or various critical structures. 7, 8 If in addition the optimization objective is a homogenous dose distribution within the PTV, 5 then the variance of the dose value distribution inside PTV has to be minimized. There is always a problem if dose points are produced within the catheter volumes which result in very short distances from the sources or even lying exactly at sources positions. The dose values at these points are very high and depend on the dwell weights assigned to the source dwell positions. These very high dose values cause wide fluctuations in the mean and maximum dose values and the corresponding χ 2 values. These fluctuations must be reduced as much as possible.
This could theoretically be avoided by using a specific cut-off maximum dose value. The disadvantages of such a method is that in the iterative process it is not known which parts of a volume are excluded in the optimization process and that the cut-off value is an arbitrary value. Another method of avoiding the numerical difficulties due to the presence of singularities is the use of the harmonic peripheral dose (HPD) proposed by Yu. 16 Both these methods deal with a problem in a manner which is not logical with regard to clinical practice. It makes no sense to calculate doses within a radioactive source or within catheters since this are non-tissue volumes. A more logical approach is the exclusion of dose points lying inside the source or the catheters. Because of this we have to test if a point is outside a catheter.
We assume that catheters are curved cylinders which can be approximated by cylindrical segments connecting sequential catheter describing points 12 and spheres centered at the nodes: these are catheter describing points belonging to two sequential segments, see Fig. 3(a) . Given the outer radius R c of a catheter, points closer than R=R c from every catheter segment and node must be excluded. In order to test if a point is inside a catheter we calculate the minimum distance between the point and any catheter segment. If it is smaller than R then this point is inside the catheter and has to be excluded.
The clinical margin ∆ R specified by the physician, can be expressed as an additional shell surrounding the catheter resulting in a corresponding increase of the effective catheter outer radius increasing this to R where R = R c + ∆ R . For the catheter types 1 we use clinically, there is a distance of 5 -10 mm between the catheter tip and the first possible source dwell position within the catheter, depending on catheter type. Knowing that the first catheter describing point is adjusted to describe the catheter tip there is no need for our catheters to define an additional margin to the tip of the catheters.
Firstly, verification is carried out to determine if a dose point P is within any of the spheres centered at the catheter nodes, Fig. 3(a) . If this is the case, then the point is inside the catheter: otherwise the following procedure for the cylindrical segments is initialized.
Given that the equation of the line for a catheter segment through the sequential catheter describing points r i and r i+1 is:
then the minimum distance of a dose point P at r p and the segment is at the point r(u min ) where r p -r(u min ) is perpendicular to the segment, Fig. 3 (a). Therefore using Eqs. (1) and (2) we obtain for the point r(u min )
where dist(r i ,r i+1 ) is the Euclidean distance between r i and r i+1 . If u min ∉ [0,1] then the point r(u min ) is not on the segment between r i and r i+1 but on one of its extensions and r p is considered to be outside this segment. If u min ∈ [0,1] then we calculate the distance of the point r p and the line segment dist(r p ,r(u min )). If dist(r p ,r(u min )) < R then the point is considered to be inside the catheter and a test for the other segments is omitted.
The length of each catheter segment dist(r i ,r i+1 ) is the most computational time consuming operation in Eq. (3) and therefore is calculated only once in a pre-processing step and the value of 1/dist(r i ,r i+1 ) 2 is stored.
It is not necessary to calculate for every dose point its distance from all catheter segments. The calculation procedure can be minimized by incorporating in the algorithm the coordinates which define the limits of the catheter segments, and extending these limits by a distance by R in each direction: this defines what we term the bounding box. A test is then necessary to determine whether any dose points are within this bounding box. If they are outside the box then they are obviously not within a catheter. If they are within the box then it must be verified that they are not within a catheter, Fig. 3 (b). Using this algorithm, which is not complicated, the test inside a catheter requires only a few seconds for 100000 sampling points.
Generation of points within a volume
Using the previously described algorithms we can generate sampling points inside an object. We produce points inside the bounding box of the object and test using our algorithm if they are inside the volume. The sampling points inside a volume are generated using triplets of so-called quasi-random sequences. These are Sobol sequences: deterministic low discrepancy sequences LDS, which fill the 3D space more uniformly than uncorrelated random points. We use the Numerical Recipes Routine sobseq which produces Sobol sequences. 17 Obtaining these sequences does not significantly lengthen the computing time compared with a time to produce the same number of pseudorandomly distributed sampling points using standard routines. It is also known that Monte Carlo integration using QR converges faster than using pseudorandom distributed sampling points. 1, 2, 17 The use of an aligned minimum bounding rectangular box 18 of the volume can further increase the speed of the generation of points inside the object. The production of points inside the minimum bounding box will increase the efficiency of the procedure by reducing the probability of generating points outside the object. This effect becomes very significant if the main axes of the object are not aligned with the coordinate system in use.
B. Points on the surface of a volume
Some dose optimization methods use points on the surface of PTV and optimize the dose distribution by requiring that a given isodose surface should ideally conform to the shape of the PTV. For these methods several disadvantages can occur as follows. Dose points are considered to be equidistant only on the contour lines of PTV, 4,5 see Fig. 4 
(a) and 4(b).
No dose points exist which are lying at the superior and inferior ends of the PTV. If the points are limited to the contours then increasing their number will not significantly improve the accuracy of the calculated dose distribution on the surface, even if there is convergence to some values for the variance of the mean, for the minimum and for the maximum dose values. This does not necessarily represent the true dose values on the whole surface of the PTV. The lack of dose points on the major part of the surface of the PTV and the restriction of dose points on its contour lines is a severe limitation if the quality of the optimization relies on the variance on the surface dose distribution. If the distance between the contours is large and there is a significant change in the shape and size of the contours from plane to plane, then the dose distribution derived from the dose points on the contour lines inaccurately represents the true dose distribution on the surface.
One approach is to use sampling points on interpolated contours. However, this method is computationaly complex and requires the calculation of new contours if one wants to increase the number of sampling points on the surface of the PTV. A different method has to be used to fill the two ends of the PTV with sampling points.
There is in the current literature in general no analytic method known for producing uniformly distributed points on the surface of an object as for example in the special case of a spherical object where points uniformly distributed on the surface of the sphere can be produced by the following algorithm.
Choose a random number s uniformly distributed in [-1, 1] and a random number φ uniformly distributed in [0, 2π] . The x, y and z coordinates of the point are given by:
The principle underlying this algorithm is that for a sphere of radius r, the area of a zone of width h is always 2πrh, regardless of where the sphere is sliced. Therefore the Zcoordinates of random points on a sphere are distributed uniformly. Points obtained by using this algorithm are then uniformly distributed on the surface of the sphere.
We have developed a simple method to generate points randomly and homogeneously distributed on the entire surface of a volume described by contours. A triangulation of the volume is assumed.
Generation of points on the surface of the PTV
We assume that the surface of the PTV is approximated by a triangulation of the contours describing the PTV with the triangles of the PTV surface forming a polyhedron. The logical idea to produce uniformly distributed points on the unfolded surface of this polyhedron and then to fold it back with the distributed points is in general not possible. For a convex polyhedron P with e edges and f faces unfolding of P is defined as a planar cell complex obtained from the boundary complex of P by cutting e-(f+1) edges of P and bending it along the remaining edges, 19 Fig. 5(a).
There is no method known for unfolding non-convex objects and even for very simple convex polyhedra there is a possibility that the unfolding produces a self-overlapping planar complex, 19 Fig. 5(b) . In order to overcome this limitation, we have developed a method which replaces the explicit folding described by a surface mapping method, that could be considered as an indirect folding procedure, and which can be applied for any type of 3D objects and surfaces.
Our method assumes that the surface of the object is triangulated. Triangles of the surface are then selected with a probability proportional to their area. Then uniformly distributed random points are produced inside the selected triangle.
If v 1 , v 2 and v 3 are the three vertices of a triangle T then its area A is given by:
Our aim is to generate uniformly distributed points on the object surface. Because of this the stochastic remainder sampling, that is, roulette wheel selection 20 is not the appropriate selection method because as already proved, this method is biased for a low number of points. 21 We decided to produce a point on a surface using the Stochastic Universal Sampling Algorithm (SUS). 21 We assign for each triangle obtained by the triangulation of the PTV surface a sector on a circle covering a fraction of the total circle area equal to the fraction of the PTV surface that is represented by the area of the triangle. On the periphery of the circle N equally distributed markers are set, where N is the number of points we want to generate on the PTV surface. All the markers are rotated by the same random angle φ on the circle periphery which will guarantee that on the average each triangle is selected with the appropriate probability independently of the sample size. At the end the number of markers lying inside the different sectors corresponding to the available triangles is recorded. Fig. 6 shows a schematic representation of the SUS algorithm 21 for a tetrahedron with 4 triangular facets. The length of the circumference of each sector A(1)-A(4) is proportional to area of each triangle. The number of markers falling into each triangle is on average proportional to the length of each sector corresponding to the triangle.
Thereafter in each triangle a number of randomly distributed points is generated equal to the number of recorded markers within the corresponding circle sector according to the following procedure. (4) we then obtain the random point P inside T.
Points generated inside a triangle with this method are uniformly distributed. Since the triangles are selected with a probability proportional to their area the points on the triangulated surface will also be uniformly distributed, Fig. 4(b) . As in the case of the volume, we also have for a surface that the points which are generated are accepted only if they are not inside catheters or inside structures.
III. MATERIAL
The material used in this study are five real clinical implants and not theoretically devised examples. They represent a typical clinical range of PTVs from < 20 cm 3 to > 500 cm 3 , of 4-12 catheters and of 20 to > 200 dwell positions, see Table I .
A. Neck implant
This example is a small volume lymph node implant in the neck with a PTV volume of 17.7 cm 3 . The 3D PTV contours and the source dwell positions within the catheters are shown in Fig. 7 .
B. Prostate implant
This example is a prostate implant made with a PTV volume of 20.7 cm 3 . The 3D PTV contours and the source dwell positions within the catheters are shown in Fig. 8 .
C. Breast implant
This example is a breast implant made with a PTV volume of 123.1 cm 3 . The 3D PTV contours and the source dwell positions within the catheters are shown in Fig. 9 .
D. Cervix implant
This example is a cervix implant made with a PTV volume of 221.4 cm 
E. Rib implant
This example is a rib implant made with a PTV volume of 504 cm 3 . The 3D PTV contours and the source dwell positions within the catheters are shown in Fig. 11 .
III. RESULTS

A. Dose points on the PTV surface
Our study has involved calculating the dose on the PTV surface using only dose points on the PTV contours and then using only dose points on the PTV surface. A comparison of these results is made with a reference which is the normal method in clinical practice. This has enabled us to assess the accuracy of normal practice. The dose distribution is calculated assuming a 1/r 2 dependence and ignoring any spatial anisotropy such as attenuation and any scattering effect. This is a reasonable approximation for this study.
We studied a high density of dose points per contour line, 4-10 points per cm, which were distributed uniformly on the PTV contour lines, see Figs. 7-11. The number of dose points used was in the range 665-2838, see Table I . We applied a dose points only optimization method and obtained a set of dwell position weights. Then we normalized these weights so that the average dose value on the PTV surface was equal to unity.
We choose dose points only optimization to estimate the dwell weights in order to be able to consider the case where the dose points have a maximum influence on the result so that we can achieve the best homogeneous dose distribution on the PTV surface.
The number of dose points uniformly distributed on the PTV contours or on the triangulated PTV surface according to our method were varied from 50 to 50000 and corresponded to surface densities of dose points in the range 0.7-1200 points /cm².
The observed minimum dose value D min , maximum dose value D max , mean dose value D mean and variance V D based on the dose points generated by the classical contour based method (CB) using PTV contours and by our 3D surface based method (SB) on the PTV surface triangulation are shown in Figs. 12-13.
The parameters we used were selected to be representative of the dose distribution on the PTV surface. In our method we have taken into account the outer diameter of the metallic needles and flexible plastic catheters. Table II gives the results of our comparison between the CB method with our new SB method , from which it is seen that the best agreement is achieved with D min but there can be wide discrepancies between the two methods for D max , D mean and V D . , that D min is very sensitive to user errors in mouse digitization and therefore great care should be taken in clinical practice if D min is to be used for dose prescription purposes. Indeed, in our opinion D min should not be used.
B. Catheters volumes
The following results have been obtained for the cervix implant using the optimization results, the dwell weights, obtained as previously described. We have calculated D min , D max , D mean and V D within the PTV as a function of the number of sampling points inside the PTV, and the outer radius of the catheters. Our results are shown in Fig. 16 .
As expected, D min is the same for all cases. The behavior of D min can be explained by the characteristic property of the quasi-random sequences, where successive points at any stage know how to fill in the gaps in the previously generated distribution. Therefore by increasing the number of sampling points one of the sampling points will come closer to the minimum than does a sampling point in the previous case. But even for a dose point density of 500 points/cm 3 corresponding to a mean grid size of 1.3 mm x 1.3 mm x 1.3 mm we can not be sure that the true minimum has been found, Fig. 16(a) .
The same behavior is observed for D max in the PTV, Fig. 16(b) , although the sudden increase of D max now depends on R. For R = 0 mm there is no limitation on the D max , whereas for R = 1 mm and R = 2 mm, D max is reached after 20000 sampling points. This corresponds to a volume dose point density of 90 points/cm 3 which is a grid size of 2.2 mm x 2.2 mm x 2.2 mm.
For D mean inside the PTV, Fig. 16(c) and for R = 1 mm and R = 2 mm, a smooth convergence to a limit is observed. D mean for R = 0 mm changes much more with the number of dose points and it increases suddenly when a new maximum dose value is reached. D mean for R = 1 mm reaches a limit at a density of 150 points/cm 3 which is a grid size of 1.9 mm x 1.9 mm x 1.9 mm. For R = 2 mm this limit is reached at a density of 30 points/cm 3 which is a grid size of 3.2 mm x 3.2 mm x 3.2 mm.
For R = 0 mm even at a density of 500 points/cm 3 which is a grid size of 1.3 mm x 1.3 mm x 1.3 mm, no convergence is observed. D mean for R = 1 mm and R = 2 mm lies within 5% of the convergence limit at a density of approximately 20 points/cm 3 which is a grid size of 3.7 mm x 3.7 mm x 3.7 mm.
The variance of the dose values inside the PTV, V D , is the quantity which is minimized in some dose optimization methods which attempt to reduce the dose inhomogeneity in the PTV. Whereas for R = 1 mm and R = 2 mm even with a small number of sampling points a good approximation of the true dose variance is observed, for R = 0 mm this quantity fluctuates in a similar way as D mean . V D for R = 1 mm lies within 5% of the convergence limit at a density of approximately 90 points/cm 3 . For R = 2 mm this is the case for a density of 50 points/cm 3 which is a grid size of 2.7 mm x 2.7 mm x 2.7 mm. For R = 0 mm even with a density of 500 points/cm 3 no convergence is observed.
Our study shows that the rejection of dose points inside the catheters not only results in realistic dose distributions inside the PTV but in addition it reduces bias and numerical instabilities produced by dose points inside catheters.
In Table III the PTV volume is given for the five implants for the cases (a) where catheter volume inside the PTV is included, (b) where catheter volume (R = 1 mm) is excluded and (c) where catheter volume and an additional margin of 1 mm (R = 2 mm) is excluded. For the clinical implants considered in our study the excluded volumes for R = 2 mm are between 2% and 12%. This effect cannot be ignored in the 3D treatment planning procedure.
IV. DISCUSSION AND CONCLUSIONS
Methods of producing dose points based on anatomical 3D information have been presented. The generation of dose points uniformly distributed on the surface of the PTV and not on the contours only, has shown that in general, more accurate D mean , D min and D max dose values on the surface of the PTV can be obtained. An improvement in the performance of the optimization methods which use V D or other dose value parameters on the PTV surface can be expected in the future. These algorithms are relatively uncomplicated and require only a few additional seconds of computing time if the correct preprocessing has been made.
The dose distribution on the PTV surface, D mean , D min, D max and V D for the whole surface are less biased than the corresponding values obtained using dose points limited to the contours of the PTV.
The D min values of the CB method show a good agreement with our SB method. The slow convergence of D min for the SB method suggests that the CB method is superior for the determination of D min . This can be explained by the fact that some of the sampling points on the contours are on the convex hull of the surface and therefore their distance to the source dwell points is maximum. Therefore the minimum dose value is usually observed on one or more of these points. We could include these sampling points in the SB method but this would not eliminate problems such as contouring errors or source position inaccuracy which affects the D min value more than it affects D mean .
The concepts of dose prescription at the minimum t arget dose level (MTD) or minimum peripheral dose (MPD) are very sensitive for even small inaccuracies in the PTV contouring process. This is demonstrated in Fig. 15 where an error by the user in the mouse digitization process for a single contour point is simulated. Even an error of 3 mm in one contour line point results for this implant in a change of the D min of 13%, Fig. 15(a) . A pixel size of typically 0.5-1.0 mm corresponds to an error of 3-6 pixels in the image. In contrast, the estimated D mean shows for a single contour point an error of 10 mm which is of less than 0.5%, Fig. 15(b) . This indicates that such user entry errors do not significantly affect the value of D mean . We have intentionally used an example of current clinical practice with the CB method as a demonstration. Figures 12-13 show that the same results are obtained using the SB method as with the CB method.
In addition to the problems which have been described, Yan Yu et al. 22 have reported that D min is very sensitive to the accuracy of the placement of seeds in permanent prostate implants. Because of these results we therefore do not recommend that D min is used to describe the dose distribution.
On the other hand, the most stable behavior is demonstrated by D mean when it is estimated on the true surface of the PTV. An accuracy of better than 1% is already achieved by surface dose point densities above 5 points/cm², see Fig. 14(c) . Even if V D convergence's to a limit when the density is above 100 points/cm², both these parameters, D mean and V D , are from our study the optimum choice to document the dose in 3D-based treatment planning for brachytherapy. 3, 23 Our study also shows that single extreme values such as D min and D max are not appropriate to document or specify brachytherapy treatments.
For a comparison of the SB and CB methods we selected, using our autoactivation algorithm, 15 only those sources which are at least 5 mm below the surface of the PTV. Without this constraint the differences between D mean , D max , and V d for the SB and CB methods are even larger, possibly because some of the source dwells could be closer to the surface. This demonstrates that the CB method yields more accurate descriptions of the dose distribution on the surface of the PTV than the CB method.
The consideration of the catheter volumes and so the exclusion of sampling points inside the catheters removes the problems encountered by very high dose values from sampling points inside the catheters and leads to true anatomical dose distributions.
Our results for sampling densities within the PTV required for an acceptable accuracy, demonstrate that in contrast to the results for an optimum grid for external beam dose studies, 1,2 where grid sizes of 5 mm x 5 mm x 5 mm, are reasonable. In brachytherapy, grid sizes of 1 mm x 1 mm x 1 mm can be required.
The analysis of the dose distributions within the PTVs is consistent with the results obtained for the PTV surface, in that D min and D max should not be used for dose optimization purposes. 6, 8, 24 Only D mean and V D can be calculated with sufficient accuracy for dose optimization, where D mean is usually indirectly used. These are the only two reliable parameters and we recommend that they are used in optimization procedures.
Current anatomy based optimization techniques are based on DVHs for PTV and normal tissues 3 . DVHs are usually calculated from sampling points randomly distributed or from sampling points forming a regular grid. Random sampling points are preferentially used due to the problem that if the points are distributed on a regular grid then it is not possible to increase their number, i.e. reduce the grid size, without the need to re-compute the DVHs. Uniformly random distributed points have the disadvantage of producing voids and clusters.
The use of deterministic low discrepancy sequences (LDS), known as quasi-random sequences, avoids this problem. 17 An important property is that they are spread out in a selfavoiding more uniformly distributed way. Since points from LDS do not use wasteful samples due to clusters and voids produced by uncorrelated random points, significantly fewer sampling points can be used in the Monte Carlo integration techniques using LDS instead of pseudo-randomly distributed points.
1,2 Even using LDS, large sampling densities are required to accurately describe DVHs. The current dose optimization algorithms in clinical practice use 300-2000 dose points in the optimization process, [3] [4] otherwise optimization time would require many hours.
However it should be realized that an accurate description of the dose distribution requires of the order of 10 5 dose points. This is a computing time problem not only for the current algorithms but also for our multiobjective genetic optimization algorithm MOGA 3 . which uses 10 5 dose points and is based on the optimization of the COIN distribution and the DVHs. 3 A significant reduction of the sampling density has to be achieved because of these time constraints and therefore an optimum distribution of dose points must be determined. The sampling points must be distributed non-uniformly and adapted to the implant geometry and to the source dwell positions. However there is a possible method of overcoming this time constraint problem using non-uniform distributed sampling points, but this has not been yet studied by any group.
VI. Each time a triangle is selected a random point is generated inside it. 
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